Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Fondazione del Piemonte per l'Oncologia
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Valerio Therapeutics
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
SCRI Development Innovations, LLC
Fox Chase Cancer Center
University of Michigan Rogel Cancer Center